These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33750347)

  • 1. The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic.
    Tan JK; Leong D; Munusamy H; Zenol Ariffin NH; Kori N; Hod R; Periyasamy P
    BMC Infect Dis; 2021 Mar; 21(1):249. PubMed ID: 33750347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implications of silent transmission for the control of COVID-19 outbreaks.
    Moghadas SM; Fitzpatrick MC; Sah P; Pandey A; Shoukat A; Singer BH; Galvani AP
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17513-17515. PubMed ID: 32632012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.
    Lee S; Kim T; Lee E; Lee C; Kim H; Rhee H; Park SY; Son HJ; Yu S; Park JW; Choo EJ; Park S; Loeb M; Kim TH
    JAMA Intern Med; 2020 Nov; 180(11):1447-1452. PubMed ID: 32780793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
    Buitrago-Garcia D; Egli-Gany D; Counotte MJ; Hossmann S; Imeri H; Ipekci AM; Salanti G; Low N
    PLoS Med; 2020 Sep; 17(9):e1003346. PubMed ID: 32960881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset.
    Cheng HY; Jian SW; Liu DP; Ng TC; Huang WT; Lin HH;
    JAMA Intern Med; 2020 Sep; 180(9):1156-1163. PubMed ID: 32356867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Outbreak and Presymptomatic Transmission in Pilgrim Travelers Who Returned to Korea from Israel.
    Park JH; Jang JH; Lee K; Yoo SJ; Shin H
    J Korean Med Sci; 2020 Dec; 35(48):e424. PubMed ID: 33316860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
    Arons MM; Hatfield KM; Reddy SC; Kimball A; James A; Jacobs JR; Taylor J; Spicer K; Bardossy AC; Oakley LP; Tanwar S; Dyal JW; Harney J; Chisty Z; Bell JM; Methner M; Paul P; Carlson CM; McLaughlin HP; Thornburg N; Tong S; Tamin A; Tao Y; Uehara A; Harcourt J; Clark S; Brostrom-Smith C; Page LC; Kay M; Lewis J; Montgomery P; Stone ND; Clark TA; Honein MA; Duchin JS; Jernigan JA;
    N Engl J Med; 2020 May; 382(22):2081-2090. PubMed ID: 32329971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of presymptomatic transmission of COVID-19: evidence from Beijing, China.
    Zhang Y; Muscatello D; Tian Y; Chen Y; Li S; Duan W; Ma C; Sun Y; Wu S; Ge L; Yang P; Jia L; Wang Q; MacIntyre CR
    J Epidemiol Community Health; 2021 Jan; 75(1):84-87. PubMed ID: 32855261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low In-School COVID-19 Transmission and Asymptomatic Infection Despite High Community Prevalence.
    Katz SE; McHenry R; Mauer LG; Chappell JD; Stewart LS; Schmitz JE; Halasa N; Edwards KM; Banerjee R
    J Pediatr; 2021 Oct; 237():302-306.e1. PubMed ID: 34144028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
    Meyers KJ; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
    J Med Virol; 2020 Nov; 92(11):2874-2879. PubMed ID: 32543722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 16. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
    Almadhi MA; Abdulrahman A; Sharaf SA; AlSaad D; Stevenson NJ; Atkin SL; AlQahtani MM
    Int J Infect Dis; 2021 Apr; 105():656-661. PubMed ID: 33647516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
    Bhandari S; Singh A; Sharma R; Rankawat G; Banerjee S; Gupta V; Dube A; Kakkar S; Sharma S; Keswani P; Agrawal A; Tak A; Nawal CL
    J Assoc Physicians India; 2020 Jun; 68(6):13-19. PubMed ID: 32610873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated Identification of Silent COVID-19 Infections Among Children and Estimated Future Infection Rates With Vaccination.
    Moghadas SM; Fitzpatrick MC; Shoukat A; Zhang K; Galvani AP
    JAMA Netw Open; 2021 Apr; 4(4):e217097. PubMed ID: 33890990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.